Gina Consylman, Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 3,594 shares at $14.66 ($53K) on 2018-02-21, disclosed to the SEC on 2018-02-22.
Scheduled sale ($53k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.66 | 376 | $6K | 10.5% |
| 2 | $14.66 | 1,298 | $19K | 36.1% |
| 3 | $14.66 | 1,920 | $28K | 53.4% |
| Total | $14.66 avg | 3,594 | $53K | 100% |
| Filing → |
| IRWD | SELL | 2020-02-25 | $217K | — | Filing → |
| IRWD | SELL | 2019-11-12 | $17K | — | Filing → |
| IRWD | SELL | 2019-08-20 | $2K | — | Filing → |